secwatch.observer — SEC 8-K summary
======================================

Issuer:     CV Sciences, Inc. (CVSI)
CIK:        0001510964
Form:       8-K
Filed at:   2025-02-11T23:59:59+00:00
Accession:  0000950170-25-018048
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 1.02, 1.01
LLM model:  deepseek-v4-flash:cloud@v2

CV Sciences disputes Extract Labs acquisition termination by Sellers; evaluating options
--------------------------------------------------------------------------------

- On Feb 5, 2025, Extract Labs owners informed CV Sciences they cannot close due to alleged failure to obtain bank consent, purportedly terminating the Stock Purchase Agreement.
- CV Sciences disputes the Sellers' right to terminate and reserves all rights; evaluating legal options.
- The Purchase Agreement was entered on Nov 21, 2024, for CV Sciences to acquire all outstanding shares of Extract Labs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1510964/000095017025018048/0000950170-25-018048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1510964/000095017025018048/cvsi-20250205.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-018048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer